1621894-64-1
Chemical Structure
Ulipristal acetate-d6
Synonym(s): CDB-2914-d6
- CAS No.: 1621894-64-1
- Formula:C30H31D6NO4
- Molecular Weight:481.66
IUPAC Name: (8S,11R,13S,14S,17R)-17-acetyl-11-(4-(bis(methyl-d3)amino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
InChIKey: OOLLAFOLCSJHRE-JBNLJIHUSA-N
SMILES: O=C1CCC2=C3[C@@]([H])(CCC2=C1)[C@@]([H])([C@@]4(C[C@@H]3C5=CC=C(C=C5)N(C([2H])([2H])[2H])C([2H])([2H])[2H])C)CC[C@@]4(C(C)=O)OC(C)=O
Biological Activity: Ulipristal acetate-d6 is deuterium labeled Ulipristal acetate. Ulipristal acetate (CDB-2914) is an orally active, selective progesterone receptor modulator (SPRM). Ulipristal acetate stimulates the autophagic response selectively in leiomyoma cells. Ulipristal acetate has the potential for benign gynecological conditions treatment, such as uterine myoma[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ulipristal acetate-d6 | Ulipristal acetate-d6 is deuterium labeled Ulipristal acetate. Ulipristal acetate (CDB-2914) is an orally active, selective progesterone receptor modulator (SPRM). Ulipristal acetate stimulates the autophagic response selectively in leiomyoma cells. Ulipristal acetate has the potential for benign gynecological conditions treatment, such as uterine myoma. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ulipristal acetate (Standard) | ≥98% | Ulipristal acetate (Standard) is the analytical standard of Ulipristal acetate. This product is intended for research and analytical applications. Ulipristal acetate (CDB-2914) is an orally active, selective progesterone receptor modulator (SPRM). Ulipristal acetate stimulates the autophagic response selectively in leiomyoma cells. Ulipristal acetate has the potential for benign gynecological conditions treatment, such as uterine myoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ulipristal acetate | 99.89% | Ulipristal acetate (CDB-2914) is an orally active, selective progesterone receptor modulator (SPRM). Ulipristal acetate stimulates the autophagic response selectively in leiomyoma cells. Ulipristal acetate has the potential for benign gynecological conditions treatment, such as uterine myoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Jadav SP, et al. Ulipristal acetate, a progesterone receptor modulator for emergency contraception. J Pharmacol Pharmacother. 2012 Apr;3(2):109-11. [Content Brief]
